Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?

Background: The effective immunization of healthcare workers (HCWs) plays a vital role in preventing the spread of SARS-CoV-2 infection during the coronavirus disease 2019 (COVID-19) pandemic. There is limited data on the immune response to vaccination among HCWs. We aim to determine seroprevalence...

Full description

Bibliographic Details
Main Authors: Lina Souan, Maher A. Sughayer, Maha M. Abualhour, Mahmoud Siag, Sara Al-Badr, Tareq Al-Atrash
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/5/642
_version_ 1797494860402393088
author Lina Souan
Maher A. Sughayer
Maha M. Abualhour
Mahmoud Siag
Sara Al-Badr
Tareq Al-Atrash
author_facet Lina Souan
Maher A. Sughayer
Maha M. Abualhour
Mahmoud Siag
Sara Al-Badr
Tareq Al-Atrash
author_sort Lina Souan
collection DOAJ
description Background: The effective immunization of healthcare workers (HCWs) plays a vital role in preventing the spread of SARS-CoV-2 infection during the coronavirus disease 2019 (COVID-19) pandemic. There is limited data on the immune response to vaccination among HCWs. We aim to determine seroprevalence rates and neutralizing IgG antibody response to various immunizations among HCWs. Methods: This study was conducted between July and September 2021, in which blood samples were obtained from HCWs and SARS-CoV-2 IgG neutralizing antibodies were measured. Data regarding vaccination status with Pfizer/BioNTech, Sinopharm, or AstraZeneca vaccines, occupation, and prior COVID-19 infection were analyzed. Results: COVID-19 infection post-vaccination was associated with higher mean antibody titers, regardless of vaccine type. Pfizer/BioNTech vaccination produced higher mean antibody titers for HCWs with prior COVID-19 infection (<i>p</i> < 0.00001) than other types of vaccines. Although 96% of HCWs were vaccinated, 3% were seronegative. For HCWs who were seropositive, there were no significant differences between the mean antibody titers when comparing occupations and blood indices. Conclusion: Awareness of the immunity status of HCWs is key to protecting this important group against SARS-CoV-2, especially those without prior COVID-19 infection. Further public health efforts regarding booster vaccination for HCWs are crucial to provide necessary antibody protection.
first_indexed 2024-03-10T01:40:23Z
format Article
id doaj.art-6ccbd5f4a85949b09af07f6fcd314ec1
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T01:40:23Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-6ccbd5f4a85949b09af07f6fcd314ec12023-11-23T13:24:47ZengMDPI AGVaccines2076-393X2022-04-0110564210.3390/vaccines10050642Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?Lina Souan0Maher A. Sughayer1Maha M. Abualhour2Mahmoud Siag3Sara Al-Badr4Tareq Al-Atrash5Department of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, JordanDepartment of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, JordanDepartment of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, JordanDepartment of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, JordanDepartment of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, JordanDepartment of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, JordanBackground: The effective immunization of healthcare workers (HCWs) plays a vital role in preventing the spread of SARS-CoV-2 infection during the coronavirus disease 2019 (COVID-19) pandemic. There is limited data on the immune response to vaccination among HCWs. We aim to determine seroprevalence rates and neutralizing IgG antibody response to various immunizations among HCWs. Methods: This study was conducted between July and September 2021, in which blood samples were obtained from HCWs and SARS-CoV-2 IgG neutralizing antibodies were measured. Data regarding vaccination status with Pfizer/BioNTech, Sinopharm, or AstraZeneca vaccines, occupation, and prior COVID-19 infection were analyzed. Results: COVID-19 infection post-vaccination was associated with higher mean antibody titers, regardless of vaccine type. Pfizer/BioNTech vaccination produced higher mean antibody titers for HCWs with prior COVID-19 infection (<i>p</i> < 0.00001) than other types of vaccines. Although 96% of HCWs were vaccinated, 3% were seronegative. For HCWs who were seropositive, there were no significant differences between the mean antibody titers when comparing occupations and blood indices. Conclusion: Awareness of the immunity status of HCWs is key to protecting this important group against SARS-CoV-2, especially those without prior COVID-19 infection. Further public health efforts regarding booster vaccination for HCWs are crucial to provide necessary antibody protection.https://www.mdpi.com/2076-393X/10/5/642COVID-19SARS-CoV-2antibody titerneutralizing antibodyIgGhealthcare workers
spellingShingle Lina Souan
Maher A. Sughayer
Maha M. Abualhour
Mahmoud Siag
Sara Al-Badr
Tareq Al-Atrash
Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
Vaccines
COVID-19
SARS-CoV-2
antibody titer
neutralizing antibody
IgG
healthcare workers
title Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
title_full Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
title_fullStr Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
title_full_unstemmed Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
title_short Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
title_sort comparison of the immunogenicity and protective efficacy of various sars cov 2 vaccines among healthcare workers are our white coat armies protected
topic COVID-19
SARS-CoV-2
antibody titer
neutralizing antibody
IgG
healthcare workers
url https://www.mdpi.com/2076-393X/10/5/642
work_keys_str_mv AT linasouan comparisonoftheimmunogenicityandprotectiveefficacyofvarioussarscov2vaccinesamonghealthcareworkersareourwhitecoatarmiesprotected
AT maherasughayer comparisonoftheimmunogenicityandprotectiveefficacyofvarioussarscov2vaccinesamonghealthcareworkersareourwhitecoatarmiesprotected
AT mahamabualhour comparisonoftheimmunogenicityandprotectiveefficacyofvarioussarscov2vaccinesamonghealthcareworkersareourwhitecoatarmiesprotected
AT mahmoudsiag comparisonoftheimmunogenicityandprotectiveefficacyofvarioussarscov2vaccinesamonghealthcareworkersareourwhitecoatarmiesprotected
AT saraalbadr comparisonoftheimmunogenicityandprotectiveefficacyofvarioussarscov2vaccinesamonghealthcareworkersareourwhitecoatarmiesprotected
AT tareqalatrash comparisonoftheimmunogenicityandprotectiveefficacyofvarioussarscov2vaccinesamonghealthcareworkersareourwhitecoatarmiesprotected